Raz Dan J, Nelson Rebecca A, Grannis Frederic W, Kim Jae Y
Division of Thoracic Surgery and Department of Biostatistics Duarte, CA.
Department of Biostatistics City of Hope Medical Center, Duarte, CA.
Chest. 2015 Apr;147(4):1111-1117. doi: 10.1378/chest.14-1960.
The natural history of typical pulmonary carcinoid tumors has not been described and has important implications for counseling elderly patients or patients with high operative-risk about surgical resection.
Data from the Surveillance, Epidemiology, and End Results Program were used to identify 4,111 patients with biopsy specimen-proven lymph node-negative typical carcinoid tumor of the lung between 1988 and 2010; 306 had no resection, 929 underwent sublobar resection, and 2,876 underwent lobectomy. Overall survival and disease-specific survival (DSS) were analyzed using Kaplan-Meier plots. Multivariate analysis was used to determine predictors of survival.
Five-year overall survival in patients who underwent lobectomy, sublobar resection, or no surgery was 93%, 92%, and 69%, respectively (P < .0001); 5-year DSS was 97%, 98%, and 88%, respectively (P < .0001). Among T1 tumors, DSS was 98% for patients who underwent lobectomy and sublobar resection and 92% for no surgery; among T2 tumors, DSS was 97%, 100%, and 87%, respectively, and among T3 and T4 tumors, it was 96%, 100%, and 75%, respectively. On multivariate analysis, nonoperative management was associated with an increased risk for disease-specific mortality compared with lobectomy (hazard ratio, 2.14; 95% CI, 1.35-3.40; P = .0013).
In this population-based cohort, surgical resection of lymph node-negative carcinoid tumors is associated with a survival advantage over nonoperative treatment. However, the DSS at 5 years was still high without any treatment, suggesting that observation of asymptomatic peripheral typical carcinoid tumors or endoscopic management of symptomatic central carcinoid tumors may be considered in patients at high risk for surgical resection.
典型肺类癌肿瘤的自然病史尚未被描述,这对于向老年患者或手术风险高的患者提供关于手术切除的咨询具有重要意义。
利用监测、流行病学和最终结果计划的数据,确定了1988年至2010年间4111例经活检标本证实为淋巴结阴性的典型肺类癌肿瘤患者;306例未行切除,929例行肺叶下切除,2876例行肺叶切除。采用Kaplan-Meier曲线分析总生存率和疾病特异性生存率(DSS)。多变量分析用于确定生存预测因素。
行肺叶切除、肺叶下切除或未手术患者的5年总生存率分别为93%、92%和69%(P <.0001);5年DSS分别为97%、98%和88%(P <.0001)。在T1肿瘤中,行肺叶切除和肺叶下切除患者的DSS为98%,未手术患者为92%;在T2肿瘤中,DSS分别为97%、100%和87%,在T3和T4肿瘤中,分别为96%、100%和75%。多变量分析显示,与肺叶切除相比,非手术治疗与疾病特异性死亡风险增加相关(风险比,2.14;95%CI,1.35 - 3.40;P =.0013)。
在这个基于人群的队列中,淋巴结阴性类癌肿瘤的手术切除与非手术治疗相比具有生存优势。然而,未经任何治疗的5年DSS仍然很高,这表明对于手术切除高风险患者,可考虑观察无症状的周围型典型类癌肿瘤或对有症状的中央型类癌肿瘤进行内镜治疗。